investor harm

Class action filed against $AMC alleging securities fraud over APE preferred equity units being excluded from special dividend after conversion to common stock.

Class action lawsuit filed against $EOSE alleging securities fraud over undisclosed production delays, battery quality issues, and false guidance during November 2025-February 2026 period.

Class action lawsuit filed against monday.com alleging false revenue and growth statements from September 2025 to February 2026. Investors urged to participate in suit.

Class action lawsuit filed against $PLUG alleging false statements about DOE funding and hydrogen facilities between January-November 2025. Investors have until April 3, 2026 to join.

Class action lawsuit filed against Mereo BioPharma over alleged misstatements regarding failed Phase 3 clinical trials. Investors have until April 6, 2026, to join.

Class action lawsuit filed against Snowflake alleging executives misled investors about product efficiency improvements and pricing changes while concealing CEO resignation plans.

Lawsuit filed against Driven Brands for securities fraud, alleging material misstatements, failed accounting controls, and overstated revenue spanning 2023-2024.

Smart Digital Group faces class action lawsuit alleging market manipulation, insider trading, and fraudulent social media promotion. Lead plaintiff deadline March 16, 2026.

Class action lawsuit filed against $CORP alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects.

Class action lawsuit filed against $NKTX alleging executives made false statements about REZOLVE-AA trial enrollment protocols, potentially harming investor value.

Class action lawsuit filed against $METC alleges executives made false statements about Brook Mine development progress. Investors from July-October 2025 urged to participate.

Class action lawsuit filed against $TCOM alleging false statements on regulatory risks from monopolistic practices. Lead plaintiff deadline: May 11, 2026.

Class action lawsuit filed against $VTGN alleges securities fraud over misleading statements about fasedienol drug candidate and PALISADE-3 clinical trial data.

Class action lawsuit filed against PayPal alleging executives made false statements about revenue projections and 2027 targets under CEO James Chriss.

Class action filed against CoreWeave ($CRWV) alleging executives made false statements about operational capabilities and customer demand fulfillment between March-December 2025. Lead plaintiff deadline: March 13, 2026.

Class action lawsuit filed against Kyndryl Holdings for alleged securities fraud, false financial disclosures, and internal control failures. Lead plaintiff deadline set for April 13, 2026.

Class action filed against Masonite alleging undisclosed Owens Corning acquisition offers while company repurchased stock at depressed prices.

Class action lawsuit filed against Paysafe alleging failure to disclose high-risk client exposure, understated credit reserves, and merchant category issues.

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about CELLECTRA device manufacturing and INO-3107 FDA submission timeline between October 2023 and December 2025.

Soleno Therapeutics faces class action lawsuit alleging failure to disclose safety concerns about DCCR drug candidate from clinical trials.